Skip to content

Frontlight ResearchEarly access

Institution

Maudsley Hospital

London, United KingdomWebsite

3running trials
1closed trial
7,528publications (OpenAlex)

Running trials

Not yet recruiting
A Study of Brenipatide in Participants With Major Depressive Disorder
NCT07928245· Phase 2· Eli Lilly and Company· Source
Recruiting
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
NCT07412756· Phase 3· Eli Lilly and Company· Source
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
NCT06976203· Phase 3· Bristol-Myers Squibb· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Depression2 recruiting
Alzheimer disease1 recruiting

Closed trials

Completed
CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia
NCT04860830· Phase 3· Boehringer Ingelheim· Source

Registry name variants (2)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

The Maudsley Hospital
London, London, City of SE5 8AZ
3 trials
- NCT07928245A Study of Brenipatide in Participants With Major Depressive Disorder
  Contact: Mario Juruena (principal investigator)
- NCT07412756A Study of Brenipatide in Adult Participants With Major Depressive Disorder
  Contact: Allan Young (principal investigator)
- NCT06976203A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
  Contact: Dag Aarsland, Site 0116
Maudsley Hospital
London, SE5 8AZ
1 trial
- NCT04860830CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia

Institution data: ROR 02788t795 (CC0-1.0)Updated 14 Nov 2026

Report an error